Based on the cost–effectiveness threshold of £30,000 or $40,000 per QALY, antiviral therapies can be recommended for influenza treatment and post-exposure prevention in high-risk patients, the ...

These results demonstrate that the stockpiling of antiviral drugs for the treatment of all symptomatic patients is a cost-effective intervention. Influenza vaccines and antiviral drugs for ...

SHELTON, CT / ACCESSWIRE / November 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the quarter ending September 30 ...

Flu symptoms and treatment are a high priority in fall and winter when the highly contagious influenza virus quickly spreads. However, you can significantly lower your risk and prevent illness by ...

The adverse event in the earlier clinical trial involved amyotrophic lateral sclerosis, which wasn't related to vaccination.

China has reported seven more H9N2 avian flu infections in humans, mostly involving children and all in people whose symptoms ...

Tivic Health has completed enrolment in a study being conducted to finetune its non-invasive vagus nerve stimulation (VNS) ...

At the first sign of a runny nose many people dash out to buy a cold and flu remedy – but soon that ... a panel of special advisers to the Food and Drug Administration (FDA) – which oversees ...

Achoo! It’s the flu season, and the virus is making its rounds looking for new carriers during this monsoon season.With cases ...

AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...